A new genetic therapy has demonstrated the ability to improve the vision of patients who would otherwise have gone blind.
It is hoped that this could have a massive benefit for the partially sighted in the future.
And a clinical study has shown that the improvement is long-lasting and so the therapy is suitable to be offered as a treatment.
Researchers are now set to apply for approval for trials to begin next year.
These will assess some of the more common forms of blindness, such as macular... Readmore
Recent research has thrown light on of the genetic link between Alzheimer's and heart disease, and the best ways to deal with the mental condition in future.
The apolipoprotein E gene known as APOE is essential to both processes, and further investigation of this genetic aspect of the critical conditions may assist progress in the future.
Yet an interesting anomaly related to Alzheimer's and heart disease is underlined by figures related to the Disease in the United States.
Currently 5.3 million... Readmore
A new study suggests that it is possible to reverse the symptoms of Alzheimer's disease by restoring proteins in the brain.
Researchers found that mice with Alzheimer's disease-like symptoms showed improvement in memory tasks after being given the protein interleukin 33 (IL-33).
It is now believed that this particular protein serves the function of boosting the immune system of the mammals.
People with Alzheimer's have previously been found to have lower levels of IL-33.
Although it is very early... Readmore
A blood test which can identify whether a person has suffered a concussion could prevent children from being exposed to medical scans which emit radiation, according to a new study.
The simple procedure pinpoints a biomarker which the brain releases following an injury.
Scientists at Orlando Health found that the glial fibrillary acidic protein biomarker can remain in the patient’s bloodstream for up to a week after the brain is impacted.
By detecting the biomarker in the blood, scientists were... Readmore
The National Institute for Health and Care Excellence (Nice) has removed acupuncture from its list of recommended treatments for lower back pain on the NHS.
Although the final decision hasn't been made, this recommendation is included in a list of draft guidelines.
Nice has cited a review of scientific evidence, which indicated that the practice was roughly equal to a placebo in treating lower back pain and sciatica.
Numerous scientific trials have now assessed the effectiveness of acupuncture,... Readmore
A study has suggested that the conventional wisdom regarding 'good' cholesterol may be incorrect after all.
The research in question was conducted at Cambridge University, and has been published in the Science journal.
Scientists found that good cholesterol is not always beneficial to the individual, which challenges orthodox opinion on the subject.
Eating olive oil, fish and nuts raises levels of high-density lipoprotein (HDL) - which is more commonly known as good cholesterol.
However, repeated... Readmore
A new drug with the potential to completely reverse the deadly Huntington's disease is currently being trialled in humans.
And researchers are very excited about the potential of this medicine, after it proved to be successful with both monkeys and mice.
The new drug, called IONIS-HTTRx, silences the gene known to be responsible for the production of a protein which causes Huntington’s.
Huntington's currently affects approximately 7,000 people in Britain.
The clinical study principal... Readmore
Researchers at the National Human Genome Research Institute in the United States believe that they have made a major breakthrough in the fight against cancer, developing a blood test that detects five types of the deadly condition.
Scientists have discovered that when breast, bowel, lung, womb or stomach cancer is present in the body, one particular gene changes its chemical signature.
It is believed that the confirmation of this new indicator for cancer could reveal a great deal more information... Readmore
The clinical trial of a new drug in France has ended disastrously, with one person brain-dead and another five people in hospital.
Investigations are ongoing into the trial which took place in a private laboratory in the western city of Rennes.
The trial was suspended as soon as problems became apparent, with the oral examination apparently having gone badly wrong.
The French Health Minister Ms Touraine said indicated that she intended to "get to the bottom... of this tragic accident."
A controversial study has suggested that taking antidepressants during pregnancy can have a serious impact on incidences of autism.
Researchers tracked just under 150,000 pregnancies and found the use of antidepressants in the second and / or third trimester of pregnancy was linked to an almost doubled risk of a child developing ASD.
The Daily Telegraph proclaimed that the study proved that “taking antidepressants during pregnancy almost doubles the risk of children developing autism”.
New research has indicated that soldiers who have served in the UK armed forces are 50 per cent more likely to develop motor neurone disease that those who have not.
The survey in question has been published in the Occupational and Environmental Medicine journal, and assesses a significance Tranche of over 57,000 armed forces veterans.
Motor neurone disease is an incurable neurodegenerative condition that attacks nerves in the brain and spinal cord.
The condition ultimately leads to progressive... Readmore
A team of researchers in Ohio is currently attempting to develop a so-called wonder drug that tackles both Alzheimer's and Type 2 diabetes.
These conditions are known for sharing two destructive proteins that play a key role in the conditions and their development.
Clinical research being carried out at the University of Akron has raised expectation that a cure for the conditions could kill both birds with one stone in the foreseeable future.
With federal funding to the order of £200,000, this... Readmore